Clinical Trial Update: Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigates whether the demethylating agent azacitidine can prevent progression from acute kidney injury to chronic kidney disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Injury

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Acute Kidney Disease | Phase 1, Phase 2 | Status: RECRUITING